|
시장보고서
상품코드
2052810
경피적 심장 판막 시장 : 제품 유형별, 전달 시스템별, 최종사용자별, 지역별Transcatheter Heart Valve Market, By Product Type, By Delivery Systems, By End User, and By Region |
||||||
경피적 심장 판막 시장은 2026년에 67억 7,000만 달러로 추정되며, 2033년까지 170억 3,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 14.1%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 67억 7,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 14.10% | 2033년 시장 규모 예측: | 170억 3,000만 달러 |
경피적 심장 판막 치환술은 판막증(VHD) 치료를 위해 생체 인공 판막을 이용하여 손상된 심장판막을 복구하는 최소침습적 심장 수술입니다. 이는 기존의 개흉수술에 대한 대안으로, 특히 고위험군 환자에게 권장되는 치료법입니다. 대동맥 판막은 심장의 왼쪽 하강(좌심실)과 신체의 주요 동맥(대동맥) 사이에 위치합니다. 이 밸브가 제대로 열리지 않으면 심장에서 몸으로 가는 혈류가 감소합니다. 경피적 대동맥판막 치환술(TAVR)은 미국 식품의약국(FDA)의 승인을 받아 증상이 있는 대동맥판막 협착증 환자 중 표준 판막 치환술의 위험성이 높은 환자의 치료법으로 승인되었습니다. TAVR은 혈류를 회복시켜 흉통, 호흡곤란, 실신, 피로감 등 대동맥판막협착증의 징후와 증상을 완화하는 데 도움이 됩니다. TAVR은 외과적 대동맥판막 치환술(개흉수술)로 인한 합병증 위험이 있는 환자들에게 하나의 대안이 될 수 있습니다. 최소침습 수술에 대한 수요가 증가함에 따라 예측 기간 동안 세계 경피적 심장 판막 시장의 성장이 촉진될 것으로 예상됩니다.
시장 역학
시장 내 주요 기업들의 제품 포트폴리오 확장을 위한 인수합병 등 비유기적 성장 전략의 채택이 증가함에 따라 예측 기간 동안 시장 성장을 견인할 것으로 예상됩니다. 예를 들어, 2021년 6월 의료기기 제조업체인 SMT는 시장 진입을 위해 구조적 심장 질환용 의료기기 제조업체인 Vascular Concepts를 인수했다고 발표했습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 조사는 다음과 같은 매개 변수를 기반으로 세계 경피적 심장 판막 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등입니다.
- 이 보고서를 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 이 세계 경피적 심장 판막 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가를 포함한 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 경피적 심장 판막 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 경피적 심장 판막 시장 : 제품 및 서비스별, 2021-2033년
제5장 세계의 경피적 심장 판막 시장 : 딜리버리 시스템별, 2021-2033년
제6장 세계의 경피적 심장 판막 시장 : 최종사용자별, 2021-2033년
제7장 세계의 경피적 심장 판막 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSM 26.06.17Transcatheter Heart Valve Market is estimated to be valued at USD 6.77 Bn in 2026 and is expected to reach USD 17.03 Bn by 2033, growing at a compound annual growth rate (CAGR) of 14.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 6.77 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 14.10% | 2033 Value Projection: | USD 17.03 Bn |
Transcatheter heart valve implantation is a minimally-invasive heart procedure to repair damaged heart valves with bio-prosthetic valves for treatment of valvular heart disease (VHD). It is an alternative approach to conventional open heart surgery and is especially recommended for extremely high risk patients. The aortic valve is located between the left lower heart chamber (left ventricle) and the body's main artery (aorta). If the valve does not open correctly, blood flow from the heart to the body is reduced. Transcatheter aortic valve replacement (TAVR) is approved by the U.S. FDA for treating individuals suffering from symptomatic aortic stenosis and are at high risk for standard valve replacement surgery. TAVR can help restore blood flow and reduce the signs and symptoms of aortic valve stenosis - such as chest pain, shortness of breath, fainting and fatigue. TAVR may be an option for people who are at risk of complications from surgical aortic valve replacement (open-heart surgery). Increasing demand for minimally-invasive procedures is expected to boost growth of the global transcatheter heart valve market over the forecast period.
Market Dynamics
Increasing adoption of inorganic growth strategies, such as acquisitions by key players in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in June 2021, SMT, a manufacturer of medical equipment, announced that it has acquired structural heart medical device firm Vascular Concepts, to enter into the market.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global transcatheter heart valve market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study are Edwards Lifesciences Corporation, Medtronic, Boston Scientific Corporation, Abbott, JenaValve Technology, SYMETIS, Braile Biomedica, CryoLife, Inc., Shockwave Medical Inc., Venus Medtech (Hangzhou) Inc.
- Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global transcatheter heart valve market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global transcatheter heart valve market.
Market Segmentation
- Global Transcatheter Heart Valve Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
- TAVR
- TMVR
- Global Transcatheter Heart Valve Market, By Delivery Systems (Revenue, USD Bn, 2021 - 2033)
- Transfemoral Approach
- Transapical Approach
- Transaortic Approach
- Global Transcatheter Heart Valve Market, By End User (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Catheterization Laboratory
- Other (Specialty Center, etc.)
- Global Transcatheter Heart Valve Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles
- Edwards Lifesciences Corporation
- Medtronic
- Boston Scientific Corporation
- Abbott, JenaValve Technology
- SYMETIS
- Braile Biomedica
- CryoLife, Inc.
- Shockwave Medical Inc.
- Venus Medtech (Hangzhou) Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product and Services
- Market Snapshot, By Delivery Systems
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Product Launch
- Technological Advancements
- PEST Analysis
- Regulatory Scenario
- Mergers and Acquisitions
4. Global Transcatheter Heart Valve Market, By Product and Services, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- TAVR
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- TMVR
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Transcatheter Heart Valve Market, By Delivery Systems, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Transfemoral Approach
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Transapical Approach
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Transaortic Approach
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Transcatheter Heart Valve Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segments Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ambulatory Surgical Center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cardiac Catheterization Laboratory
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others (Specialty Center, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Transcatheter Heart Valve Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery System, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Edwards Lifesciences Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Medtronic
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- JenaValve Technology
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- SYMETIS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Braile Biomedica
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CryoLife, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Shockwave Medical Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Venus Medtech (Hangzhou) Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
